Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell Lymphoma

CONCLUSIONS: In summary, FLOT2 functions as an oncogene and is linked to DLBCL prognosis and the tumor microenvironment. Targeting FLOT2 deletion emerges as a novel strategy to impede DLBCL aggressiveness by inhibiting cell proliferation and invasion, ultimately inducing apoptotic cell death.PMID:38531803 | DOI:10.24976/Discov.Med.202436182.59

Source: Discovery Medicine - March 26, 2024 Category: Research Authors: Yujing Zhang Yao Chen Qiang Guo Ying Zhang Aichun Liu Source Type: research